A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

A tiny molecule called a nanobody may succeed where today's cancer drugs often fail, according to University of Hawaiʻi at ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

New research has shown that nanobody treatments that block PD-L1 can reduce tumor growth by about 50% in cancers that don't ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

But recently, scientists took inspiration for such a super drug from a quiet corner of the medical world: The small subset of ...

Up to 88 percent of the mice in the study remained tumor-free, and the team are now turning their attention to human cancers.

In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed ...

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency announced ...

The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert ...